Regional hub for the Greater Mekong subregion

Mother and child at LLIN distribution in Ratanakiri, Cambodia
Sarah Hoibak

In April 2013, WHO launched an emergency response to artemisinin resistance in the Greater Mekong subregion. A new framework for action, covering 2013-2015, was developed, proposing an immediate and coordinated scale-up of malaria interventions and containment efforts in Cambodia, the Lao People’s Democratic Republic, Myanmar, Thailand and Viet Nam. A dedicated regional hub was set up in Cambodia, with a network of technical officers placed in WHO Country Offices in affected countries. This website section brings together all information related to the work of the Regional hub.

Information about our work

Malaria elimination strategy for the Greater Mekong subregion

The Strategy for malaria elimination in the Greater Mekong subregion (2015–2030) was drafted under the aegis of the Regional Hub for the Emergency Response to Artemisinin Resistance in coordination with countries and regional partners.

Background on the Emergency response to artemisinin resistance in the Greater Mekong subregion

This projects seeks to strengthen the regional response to artemisinin resistance by coordinating action across countries, strengthening technical leadership and catalysing resource mobilization.

Activities for the monitoring and containment of artemisinin resistance

Successful containment of artemisinin resistant parasites will require urgent and coordinated action by a consortium of partners, including affected countries, funders, implementing agencies and global malaria partners. Read more about technical support offered by WHO.

Key documents

General documentation

These documents provide guidance on various issues in the context of migrant and mobile populations.

Technical reports

Reports of technical and informal consultations on malaria control in the subregion.

Plans and strategies

National plans and response strategies for malaria control in the subregion.

Therapeutic efficacy studies

These reports provide essential insight on antimalarial therapeutic efficacy in the subregion.